BackgroundTuberculosis (TB), Lung Cancer (LC) and Chronic Obstructive Pulmonary Diseases (COPD) affect millions of individuals worldwide. Monitoring of DNA damage in pathological situations has been investigated because it can add a new dimension to clinical expression and may represent a potential target for therapeutic intervention. The aim of this study was to evaluate DNA damage and the frequency of cellular abnormalities in TB, LC and COPD patients by comparing them to healthy subjects.MethodsThe detection of DNA damage by a buccal micronucleus cytome assay was investigated in patients with COPD (n = 28), LC (n = 18) and TB (n = 22) and compared to control individuals (n = 17).ResultsThe COPD group had a higher frequency of apoptotic cells compared to TB and LC group. The TB group showed a higher frequency of DNA damage, defect in cytokinesis, apoptotic and necrotic cells. Patients with LC had low frequency of chromosomal aberrations than TB and COPD patients.ConclusionCOPD patients showed cellular abnormalities that corresponded to cell death by apoptosis and necrosis, while patients with TB presented defects in cytokinesis and dysfunctions in DNA repair that resulted in the formation of micronucleus (MN) besides apoptotic and necrotic cells. Patients with COPD, TB and LC had a low frequency of permanent DNA damage.

RESUMOAcredita-se que fatores genéticos podem modificar o risco individual tornando os indivíduos mais susceptíveis a certas patologias. Polimorfismos de nucleotídeo único (SNP) em genes de mediadores inflamatórios estão fortemente relacionados a esta propensão. Objetivou-se relacionar a presença de SNP em gene que codifica uma citocina pró-inflamatória com susceptibilidade às doenças pulmonares. Foi realizado um estudo do tipo caso-controle em indivíduos com doença pulmonar obstrutiva crônica (DPOC), câncer de pulmão (CP) e tuberculose (TB). Foram realizadas coletas de dados epidemiológicos e ainda de material biológico para genotipagem do polimorfismo rs1800795 do gene IL6 através da técnica de reação em cadeia da polimerase (PCR) em tempo real. Para as análises estatísticas foram avaliadas a frequência (%), média e desvio-padrão e o teste x 2 para as variáveis categóricas. Observou-se o predomínio do sexo masculino, bem como a maioria dos indivíduos se autodeclarou caucasiano. Quanto à frequência alélica para o polimorfismo rs1800795 do gene IL6, a presença foi maior no alelo considerado de risco em todos os grupos de casos, mas ao comparar estes achados a um grupo controle, não foi observada diferença estatística significativa, fato que demonstra que não há relação entre as frequências genotípicas e alélicas e presença do polimorfismo em IL6 com a susceptibilidade a doenças pulmonares nesta população.Palavras-chave: Doenças pulmonares. Interleucina 6. Susceptibilidade. Citocinas inflamatórias. Polimorfismos genéticos. ABSTRACTIt is believed that genetic factors may modify the individual risk making individuals more susceptible to certain diseases. Single nucleotide polymorphisms (SNP) in inflammatory mediators genes are strongly related to this propensity. The objective was to correlate the presence of SNPs in the gene encoding a pro-inflammatory cytokine with susceptibility to lung diseases. A study was conducted case-control in patients with chronic obstructive pulmonary disease (COPD), lung cancer (PC) and tuberculosis (TB). Epidemiological data collection and also of biological material were performed for genotyping of the IL6 gene polymorphism rs1800795 by polymerase chain reaction (PCR) in real time. For statistical analysis were evaluated the frequency (%), mean and

Background: Tuberculosis (TB), Lung Cancer (LC) and Chronic Obstructive Pulmonary Diseases (COPD) affect millions of individuals worldwide. Monitoring of DNA damage in pathological situations has been investigated because it can add a new dimension to clinical expression and may represent a potential target for therapeutic intervention. The aim of this study was to evaluate DNA damage and the frequency of cellular abnormalities in TB, LC and COPD patients by comparing them to healthy subjects. Methods: The detection of DNA damage by a buccal micronucleus cytome assay was investigated in patients with COPD (n = 28), LC (n = 18) and TB (n = 22) and compared to control individuals (n = 17). Results: The COPD group had a higher frequency of apoptotic cells compared to TB and LC group. The TB group showed a higher frequency of DNA damage, defect in cytokinesis, apoptotic and necrotic cells. Patients with LC had low frequency of chromosomal aberrations than TB and COPD patients. Conclusion: COPD patients showed cellular abnormalities that corresponded to cell death by apoptosis and necrosis, while patients with TB presented defects in cytokinesis and dysfunctions in DNA repair that resulted in the formation of micronucleus (MN) besides apoptotic and necrotic cells. Patients with COPD, TB and LC had a low frequency of permanent DNA damage.